Chrono Therapeutics is a pharmaceutical company founded in 2004 with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) coupled with real-time behavioral support. Chrono’s executive leadership combines years of professional experience and personal passions for developing life-saving medical products. Chrono's flagship product is designed to help smokers overcome their deadly addiction to nicotine. Our wearable device offers personalized, transdermal nicotine replacement therapy (NRT) in combination with real-time behavioral support. Research shows that smokers have clear, consistent and predictable daily peak nicotine craving patterns; our system is designed to automatically vary nicotine levels throughout the day to match those patterns. The device uses Bluetooth technology to wirelessly communicate with Chrono's digital behavioral support program, providing real-time guidance to help smokers cope with cravings as well as a means for promoting compliance to the NRT and overall quit process.
Looking for a particular Chrono Therapeutics employee's phone or email?
The Chrono Therapeutics annual revenue was $5 million in 2026.
Chrono Therapeutics is based in Oxford, Oxfordshire.
The NAICS codes for Chrono Therapeutics are [3254, 325, 32541, 32].
The SIC codes for Chrono Therapeutics are [283, 28].